Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05158244
What this trial is testing

Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 34
Not applicableStudy completedNCT03845114
What this trial is testing

Insulin-based Strategies to Prevent Hypoglycemia During Two Types of Exercise

Who this might be right for
Type 1 Diabetes Mellitus
Institut de Recherches Cliniques de Montreal 37
Early research (Phase 1)Study completedNCT01055652
What this trial is testing

Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 28
Not applicableNot Yet RecruitingNCT07420972
What this trial is testing

Pilot Study of Intrapartum Insulin Pump

Who this might be right for
DiabetesDiabetes (Insulin-requiring, Type 1 or Type 2)Pregnancy
Medstar Health Research Institute 30
Not applicableStudy completedNCT01873066
What this trial is testing

Closing the Loop 24/7 in Adolescents With Type 1 Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 1Glucose Metabolism Disorders+1 more
University of Cambridge 24
Early research (Phase 1)WithdrawnNCT04001231
What this trial is testing

Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
AstraZeneca
Not applicableStudy completedNCT07522502
What this trial is testing

Metabolic and Immunoinflammatory Profiles in Adults With Newly Diagnosed Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Autoimmune Diabetes
West Kazakhstan Marat Ospanov Medical University 240
Not applicableStudy completedNCT03539627
What this trial is testing

Azilsartan Medoxomil in Hypertensive pAtients With Stable Ischemic Heart Disease and DiabEtes MEllitus.

Who this might be right for
Arterial HypertensionDiabetes MellitusStable Chronic Angina
Research Institute for Complex Problems of Cardiovascular Diseases, Russia 184
Early research (Phase 1)Study completedNCT00214786
What this trial is testing

Pancreatic Islet Cell Transplantation

Who this might be right for
Type 1 Diabetes
Baylor Research Institute 4
Not applicableStudy completedNCT01538589
What this trial is testing

Special Survey for Patients With Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,582
Not applicableStudy completedNCT00675220
What this trial is testing

Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 373
Testing effectiveness (Phase 2)UnknownNCT05333835
What this trial is testing

A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 455
Large-scale testing (Phase 3)Study completedNCT01885208
What this trial is testing

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 813
Testing effectiveness (Phase 2)Study completedNCT03514420
What this trial is testing

Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)

Who this might be right for
Familial Partial Lipodystrophy
Akcea Therapeutics 4
Not applicableStudy completedNCT04344210
What this trial is testing

Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus

Who this might be right for
COVIDDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Federal University of Rio Grande do Sul 149
Early research (Phase 1)Study completedNCT01650324
What this trial is testing

A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects

Who this might be right for
Diabetes Mellitus, Type 2
National Health Research Institutes, Taiwan 32
Early research (Phase 1)Study completedNCT00501462
What this trial is testing

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2Renal Insufficiency
GlaxoSmithKline 29
Not applicableStudy completedNCT05977205
What this trial is testing

COVID-19 Glycemic Control Study

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Leiden University Medical Center 492
Not applicableStudy completedNCT02117622
What this trial is testing

A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in India

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,056
Not applicableStudy completedNCT00788853
What this trial is testing

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Indonesia

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,832
Next Page